HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Packaging Regulation Presents Challenge And Opportunity For Consumer Health Industry

Executive Summary

A proposed new European Union packaging regulation, which introduces environmental and labelling requirements and extended producer responsibility for medicines, medical devices and food supplements, could be challenging for the region's consumer health industry. But it could also be a spur to creativity, argues Chris Whitehouse, chairman and managing director of Whitehouse Communications.

You may also be interested in...



The E in ESG: Consumer Health Compliance Will Not Be Optional For Much Longer

European consumer health companies have the luxury of voluntarily setting sustainability goals. But with regulations looming and pressure from retailers and consumers mounting, compliance with mandatory standards is on the horizon, says Haleon’s sustainability chief Joe Muscat.

AESGP Annual Meeting: Sustainability Optional Now, But Not For Long, Warns Haleon

European consumer health companies today have the luxury of voluntarily setting sustainability goals. But with regulations looming and pressure from retailers and consumers mounting, such requirements will soon be mandatory, Haleon’s Joe Muscat warned at the recent AESGP Annual Meeting in Paris, France. To ride the climate wave, while achieving their objectives, OTC firms need to work together, he explained.

Haleon Supports EU Packaging Proposals But Has ‘Serious Concerns’ About Timings

Haleon says it “supports the overall ambitions” of the European Commission’s proposals for a new Regulation on Packaging and Packaging Waste, but has “serious concerns” about the timelines established in the proposal, for example that all medicines packaging should be recyclable by 2035.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153515

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel